Global availability of parenteral nutrition: Pre- and post-COVID-19 pandemic surveys.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Klek Stanislaw, Del Rio Requejo Isabel Martinez, Hardy Gil, Francisco Liza Mei P, Abbasoglu Osman, Acosta Juan Carlos Ayala, Granados Luis Miguel Becerra, Boeykens Kurt, Carey Sharon, Chourdakis Michael, Compher Charlene, De Cloet Joeri, Dubrov Sergiej, Fuentes Catalina, Sámano Ana Karina García, Velasquez María Eloisa García, Goos Cezanne, Reyes José Guillermo Gutierrez, Joon Lee V, Klimasauskas Andrius, Komsa Regina, Krznaric Zeljko, Ljubas Dina, Moscoso Claudia P Maza, Larreategui Rosa, Mirea Liliana, Meier Remy, Nyulasi Ibolya, Oivind Irtun, Panisic-Sekeljic Marina, Poulia Kalliopi Anna, Rasmussen Henrik Højgaard, Savino Patricia, Singer Pierre, Tamasi Peter, Uyar Mehmet, Thu Nguyen Viet Quynh, Waitzberg Dan, Weimann Arved, Wong Theodoric, Yu Jianchun, Wojcik Paulina, Schneider Stephane
Аннотация
METHODS: An international survey using an electronic questionnaire was conducted in August 2019 and repeated in May 2022. An electronic questionnaire was sent to 52 members or affiliates of the International Clinical Nutrition Section of the American Society for Parenteral and Enteral Nutrition. Questions addressed the availability of parenteral nutrition admixtures and their components, reimbursement, and prescribing pre- and post-COVID-19 pandemic. All participating countries were categorized by their economic status.
RESULTS: Thirty-six country representatives responded, answering all questions. Parenteral nutrition was available in all countries (100%), but in four countries (11.1%) three-chamber bags were the only option, and in six countries a multibottle system was still used. Liver-sparing amino acids were available in 18 (50%), kidney-sparing in eight (22.2%), and electrolyte-free in 11 (30.5%) countries (30.5%). In most countries (n = 28; 79.4%), fat-soluble and water-soluble vitamins were available. Trace elements solutions were unavailable in four (11.1%) countries. Parenteral nutrition was reimbursed in most countries (n = 33; 91.6%). No significant problems due to the coronavirus pandemic were reported.
CONCLUSIONS: Despite the apparent high availability of parenteral nutrition worldwide, there are some factors that may have a substantial effect on the quality of parenteral nutrition admixtures. These shortages create an environment of inequality.